The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 63 people, planned
- Started
- 4 Aug 2025
- Expected to end
- 1 Aug 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
- 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion
- 25 mg Diphenhydramine (5 min) + Normal Saline
- Record updated
- 10 September 2026
Who can take part
- Age
- 21 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) diagnosis of Alcohol Use Disorder
- Medically healthy
- Ability to provide consent
Who cannot take part
- Unstable medical conditions
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Alcohol-related disorders or alcohol use
This trial is currently available in United States.
- Connecticut Mental Health CenterNew Haven, United StatesContact: Anahita Bassir Nia, MDTaking people
About the trial
What the trial wants to find out
This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.
The 3 groups in the trial
- Group 1Existing treatment, for comparison
Bolus of 0.3mg/kg/min DMT (5min) + Normal Saline infusion (60 min)
Treatment: 0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
- Group 2Existing treatment, for comparison
Bolus of 0.2 mg/kg/min DMT (5 min) + 0.01mg/kg/min infusion (60 min)
Treatment: 0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion
- Group 3Placebo, for comparison
Bolus of 25 mg Diphenhydramine (5 min) + Normal Saline infusion (60 min)
Treatment: 25 mg Diphenhydramine (5 min) + Normal Saline
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06070649, who can take part
- Record updated
- 10 September 2026